Non-communicable Diseases and COVID-19; a double-edged sword A Special Communication from IRAN

Peykari, Niloofar; Eybpoosh, Sana; Safikhani, Hamidreza; Haghdoost, Ali Akbar; Tabatabaei‐Malazy, Ozra; Larijani, Bagher

doi:10.1007/s40200-020-00683-1

Cited by 9 publications

(12 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Non-communicable diseases have been the leading causes of death in Iran in recent years so that, more than 76% of deaths are due to noncommunicable diseases in Iran. Cardiovascular diseases accounted for 45.7%, cancers for 13.5% and respiratory diseases for about 4% of deaths (11).On February 19, 2020, the first cases of corona virus disease were detected in Iran (12).Based on the article by Peykari& et al, patients with at least one co-morbidity were 30.2% and the percent of death due to COVID-19 that had at least one co-morbidity was 37.9% (13).…”

Section: Introductionmentioning

confidence: 99%

Comorbidity and Its Impact on Mortality of COVID-19 in Yazd Province, a Central part of Iran: a Hospital-based study

Soodejani¹,

Hosseini²,

Sefidkar³

et al. 2022

JCHR

View full text Add to dashboard Cite

Introduction: The World Health Organization on March 11, 2020 declared the outbreak of severe acute respiratory syndrome Corona virus 2 disease (COVID-19) a pandemic situation. The main aim of this study was investigating mortality of COVID-19 by considering chronic diseases. methods: This study was conducted as a cross-sectional in which all confirmed cases were examined. The variables considered in this study were age, sex, diabetes mellitus, cancers, hypertension, heart diseases, kidney diseases, and liver diseases. Independent sample t test, Chi-square and binary logistic regression were used for data analysis. All statistical analysis was done in SPSS 16 and significant level was set at 0.05. Results: Out of 22849 PCR and CT scan tests, 16061 were positive. According to the confirmed cases, prevalence of COVID-19 was calculated about 0.019. Also hospital case fatality rate and mortality rate were calculated 156 and about 8.2 per 100000 respectively. Hypertension, and age had significant relationship with morbidity of COVID-19, in other hand, age (OR: 4.51, p<0.001), kidney diseases (OR: 1.84, p<0.001), diabetes mellitus (OR: 1.31, p<0.001), cancer (OR: 2.73, p<0.001), liver diseases (OR: 2.27, p<0.001) had impact on mortality of covid-19. Population Attributable Fraction (PAF) showed the most fraction of death was due to diabetes mellitus, cancers, kidney diseases, and liver diseases. Conclusion: Age and some underlying diseases increase odds of death due to COVID-19. It seems that preventing high-risk people from being infected is an effective solution to reduce COVID-19 death rate. To do this, health protocols need to be implemented more seriously for these sensitive groups.

show abstract

Section: Introductionmentioning

confidence: 99%

Comorbidity and Its Impact on Mortality of COVID-19 in Yazd Province, a Central part of Iran: a Hospital-based study

Soodejani¹,

Hosseini²,

Sefidkar³

et al. 2022

JCHR

View full text Add to dashboard Cite

show abstract

“…We also found examples of cross-platform communication campaigns. For example, Iranian Red Crescent and the MoHME implemented several measures for public awareness, such as research, training and planning workshops; infographics in Farsi, Arabic, and Turkish; public awareness posters; text messages; media training; and materials for the deaf and other marginalized groups (Peykari et al, 2020). The MoHME also used phone messages to counter social media-induced panic.…”

Section: Integrated Communication Campaignsmentioning

confidence: 99%

Pulse-Check: Exploration of Early COVID-19 Pandemic Health Care and Public Health Responses in Select Middle East Nations

2022

View full text Add to dashboard Cite

“…Furthermore, this increase in COVID-19 cases in all age groups and among people with underlying disease conditions causes hospital settings to be overwhelmed due to patient overload, and services regarding noncommunicable diseases (NCDs) may be interfered due to COVID-19 mitigation response [12]. In Rwanda, strategies to help people with NCDs to access essential care during this pandemic were available, where allowances/ passes to seek medical services for all people were granted during the national lockdown and curfew periods.…”

Section: Introductionmentioning

confidence: 99%

Severity Status of COVID-19 and Its Associated Factors at the Nyarugenge Treatment Center in Rwanda

Ntambara¹,

Munyanshongore²,

Ndahindwa³

2023

Cureus

View full text Add to dashboard Cite

BackgroundThe COVID-19 pandemic has continued to be a public health emergency currently; on March 11, 2020, the World Health Organization (WHO) declared it a global pandemic. Despite the Rwanda National Health Measures that have been put in place to protect the public including lockdowns, curfew, face mask mandate, handwashing sensitization, etc., severe morbidity and mortality cases of COVID-19 are continued to be seen. Some studies have linked COVID-19 complications to its direct chain of mechanism; however, other studies have linked comorbidity or underlying disease conditions to its poor prognosis. Studies have not yet been conducted in Rwanda on the severe status of COVID-19 and its associated factors among patients. Therefore, this study aimed to assess the severe status of COVID-19 and its associated factors at the Nyarugenge Treatment Center. MethodsA descriptive cross-sectional study was done. All patients admitted to the Nyarugenge Treatment Center from January 8, 2021, when the hospital opened, until the end of May 2021 were recruited in the study. The eligible participants were all patients who were admitted and tested positive for COVID-19 by RT-PCR method according to the Rwanda Ministry of Health criteria. ResultsAll data were analyzed using the Statistical Package for the Social Sciences (SPSS) software, version 25 (IBM Corp., Armonk, NY). The number of patients admitted during the study period was 648, with a median age of 53; 45.2% of them were females, and 54.2% were males. Of these, 81.2% (526) were discharged from the hospital, while 18.8% (122) died. The proportion of severe status of COVID-19 was 42.1%. The factors that showed a risk of severe COVID-19 status were age and the number of comorbidities. Patients aged above 60 years (OR = 11.7, and those between the age of 51 and 60 (OR = 6.86, 95% CI: 2.96-15.93, p-value < 0.001) were 12 and seven times more likely to have severe COVID-19 status compared to those aged below 30 years. Having two comorbidities had twice the risk of developing a severe COVID-19 status compared to those with no comorbidity (OR = 2.13, 95% CI: 1.20-3.77, p-value < 0.001). ConclusionElderly people and those with comorbidities are encouraged to obtain all standard operating procedures and comply with the vaccination program.

show abstract

Non-communicable Diseases and COVID-19; a double-edged sword A Special Communication from IRAN

Cited by 9 publications

References 26 publications

Comorbidity and Its Impact on Mortality of COVID-19 in Yazd Province, a Central part of Iran: a Hospital-based study

Comorbidity and Its Impact on Mortality of COVID-19 in Yazd Province, a Central part of Iran: a Hospital-based study

Pulse-Check: Exploration of Early COVID-19 Pandemic Health Care and Public Health Responses in Select Middle East Nations

Severity Status of COVID-19 and Its Associated Factors at the Nyarugenge Treatment Center in Rwanda

Contact Info

Product

Resources

About